CEO
EUROAPI
Equibles does not estimate personal net worth.
David Seignol is recorded as CEO at EUROAPI. David Seignol has spoken on 1 earnings call across 1 company, most recently for EUROAPI on March 3, 2026. EUROAPI is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Let me begin on page 5 with a key takeaway from 2025. Our teams fought on North France to protect our market position in an increasingly competitive environment, for example vitamin B12 as mentioned here.”
EUROAPI
CEO
Transcript header (unverified)
EUROAPI
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
2025 Full-Year Results
EUROAPI
